The Sayer Clinic Limited 02166431 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is Complimentary Health Digita Accounts Production Advanced 6.30.9574.0 true true 02166431 2023-01-01 2023-12-31 02166431 2023-12-31 02166431 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2023-12-31 02166431 core:RetainedEarningsAccumulatedLosses 2023-12-31 02166431 core:RevaluationReserve 2023-12-31 02166431 core:ShareCapital 2023-12-31 02166431 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 02166431 core:FurnitureFittingsToolsEquipment 2023-12-31 02166431 core:MotorVehicles 2023-12-31 02166431 bus:SmallEntities 2023-01-01 2023-12-31 02166431 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 02166431 bus:FilletedAccounts 2023-01-01 2023-12-31 02166431 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 02166431 bus:RegisteredOffice 2023-01-01 2023-12-31 02166431 bus:CompanySecretaryDirector1 2023-01-01 2023-12-31 02166431 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2023-01-01 2023-12-31 02166431 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 02166431 core:RevaluationReserve core:LandBuildings 2023-01-01 2023-12-31 02166431 core:FurnitureFittings 2023-01-01 2023-12-31 02166431 core:FurnitureFittingsToolsEquipment 2023-01-01 2023-12-31 02166431 core:LandBuildings 2023-01-01 2023-12-31 02166431 core:MotorVehicles 2023-01-01 2023-12-31 02166431 core:OfficeEquipment 2023-01-01 2023-12-31 02166431 countries:England 2023-01-01 2023-12-31 02166431 2022-12-31 02166431 core:FurnitureFittingsToolsEquipment 2022-12-31 02166431 core:MotorVehicles 2022-12-31 02166431 2022-01-01 2022-12-31 02166431 2022-12-31 02166431 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2022-12-31 02166431 core:RetainedEarningsAccumulatedLosses 2022-12-31 02166431 core:RevaluationReserve 2022-12-31 02166431 core:ShareCapital 2022-12-31 02166431 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 02166431 core:FurnitureFittingsToolsEquipment 2022-12-31 02166431 core:MotorVehicles 2022-12-31 02166431 core:RevaluationReserve core:LandBuildings 2022-01-01 2022-12-31 02166431 core:LandBuildings 2022-01-01 2022-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 02166431

The Sayer Clinic Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2023

 

The Sayer Clinic Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 8

 

The Sayer Clinic Limited

Company Information

Director

Mrs C Durtnall

Company secretary

Mrs C Durtnall

Registered office

8 Sunningdale Gardens
Stratford Road
Kensington
London
W8 6PX

Accountants

Clever Accounts Limited
Brookfield Court
Selby Road
Leeds
LS25 1NB

 

The Sayer Clinic Limited

(Registration number: 02166431)
Balance Sheet as at 31 December 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

42,250

53,616

Investment property

5

8,525

21,325

 

50,775

74,941

Current assets

 

Cash at bank and in hand

 

386,076

554,926

Creditors: Amounts falling due within one year

(8,699)

(12,059)

Net current assets

 

377,377

542,867

Net assets

 

428,152

617,808

Capital and reserves

 

Called up share capital

6

100

100

Revaluation reserve

(196,460)

(196,460)

Retained earnings

624,512

814,168

Shareholders' funds

 

428,152

617,808

For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

 

The Sayer Clinic Limited

(Registration number: 02166431)
Balance Sheet as at 31 December 2023

Approved and authorised by the director on 3 September 2024
 

.........................................

Mrs C Durtnall
Company secretary and director

 

The Sayer Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
8 Sunningdale Gardens
Stratford Road
Kensington
London
W8 6PX
England

These financial statements were authorised for issue by the director on 3 September 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

The Sayer Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures & Fittings

15% Reducing Balance

Office Equipment

33% Straight Line

Motor Vehicles

25% Reducing Balance

Investment property

Investment property is carried at fair value, derived from the current market prices for comparable real estate determined annually by external valuers. The valuers use observable market prices, adjusted if necessary for any difference in the nature, location or condition of the specific asset. Changes in fair value are recognised in profit or loss.

Investments

An investment is carried at fair value, derived from the current market prices for comparable investments determined annually by external valuers. The valuers use observable market prices, adjusted if necessary for any difference in the age, location or condition of the specific asset. Changes in fair value are recognised in profit or loss.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

The Sayer Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 3 (2022 - 4).

 

The Sayer Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 January 2023

192,634

108,955

301,589

Additions

2,103

-

2,103

At 31 December 2023

194,737

108,955

303,692

Depreciation

At 1 January 2023

180,620

67,353

247,973

Charge for the year

3,159

10,310

13,469

At 31 December 2023

183,779

77,663

261,442

Carrying amount

At 31 December 2023

10,958

31,292

42,250

At 31 December 2022

12,014

41,602

53,616

5

Investment - Classic Car

2023
£

At 1 January

136,500

Additions

(127,975)

At 31 December

8,525

There has been no valuation of investments by an independent valuer.

6

Share capital

Allotted, called up and fully paid shares

2023

2022

No.

£

No.

£

Ordinary Shares of £1 each

100

100

100

100

       
 

The Sayer Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

7

Reserves

The changes to each component of equity resulting from items of other comprehensive income for the current year were as follows:

Revaluation reserve
£

Total
£

Surplus/deficit on property, plant and equipment revaluation

(196,460)

(196,460)

The changes to each component of equity resulting from items of other comprehensive income for the prior year were as follows:

Revaluation reserve
£

Total
£

Surplus/deficit on property, plant and equipment revaluation

(196,460)

(196,460)